REALTIME
Device
Abbott Laboratories
Total Payments
$84,908
Transactions
12
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $71,650 | 2 | 0 |
| 2022 | $13,258 | 10 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $42,343 | 1 | 49.9% |
| Unspecified | $40,197 | 3 | 47.3% |
| Debt forgiveness | $1,261 | 4 | 1.5% |
| Travel and Lodging | $958.38 | 1 | 1.1% |
| Food and Beverage | $148.73 | 3 | 0.2% |
Payments by Type
General
$44,711
9 transactions
Research
$40,197
3 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Alinity m BKV Assay Clinical and Reproducibility Testing Study | Abbott Laboratories | $29,307 | 0 |
| SARS-CoV-2 screening in cancer outpatients during the second wave of the COVID-19 pandemic | Abbott Laboratories | $10,890 | 0 |
Top Doctors Receiving Payments for REALTIME
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Tulsa, OK | $83,801 | 8 |
| , M.D | Allergy & Immunology | Atlanta, GA | $1,107 | 4 |
Ad
Manufacturing Companies
- Abbott Laboratories $84,908
Product Information
- Type Device
- Total Payments $84,908
- Total Doctors 1
- Transactions 12
About REALTIME
REALTIME is a device associated with $84,908 in payments to 1 healthcare providers, recorded across 12 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2022 to 2023. In 2023, $71,650 was paid across 2 transactions to 0 doctors.
The most common payment nature for REALTIME is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($42,343, 49.9% of total).
REALTIME is associated with 2 research studies, including "Alinity m BKV Assay Clinical and Reproducibility Testing Study" ($29,307).